LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Smart Intraocular Lens Inserted into the Eye Detects Biomarkers for Alzheimer's

By LabMedica International staff writers
Posted on 13 Jan 2023
Print article
Image: Lens used in the development of smart intraocular lenses (Photo courtesy of KIMM)
Image: Lens used in the development of smart intraocular lenses (Photo courtesy of KIMM)

Scientists have developed a smart intraocular lens that can be inserted into the eye to detect biomarkers for Alzheimer's, a degenerative brain disease, and could facilitate early diagnosis of various other neurological diseases.

The smart intraocular lens that can be inserted into the eye to diagnose Alzheimer's has been developed for the first time in Korea by scientists at The Korea Institute of Machinery and Materials (KIMM, Daejeon, Korea). The intraocular implant can diagnose Alzheimer's in its early stages. The scientists developed the implantable biosensing system by mounting a bioresponsive hydrogel-based sensing module that can detect various biomarkers on an intraocular lens to express a signal in a moiré pattern.

The hydrogel pattern, to which the antibody is bound, contracts when it reacts with the target biomarker which is then detected using changes in the moiré signal. These changes are generated when the hydrogel pattern, which becomes narrower by the contraction response, overlaps with the designated reference grid. The use of a moiré signal makes detection possible with much greater sensitivity as compared to other methods that directly detect change in the hydrogel pattern.

In addition, unlike traditional biosensors, the moiré signal-based biomarker detection method is capable of directly detecting biomarkers without the use of electrochemical or fluorescent labels. This method eliminates the requirement for external power or a light source, allowing it to be implanted within the body. The scientists consider the development of this technology to be significant as it can minimize social costs by diagnosing neurological diseases, including dementia, which is common and results in social issues.

Related Links:
KIMM 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more